MYC and neoplasm: Conversely, inhibition of c‐MYC expression is thought to be also an essential mechanism by which BET inhibitors suppress tumor progression in hematological malignancies (Knoechel et al, 2014; Roderick et al, 2014; Trabucco et al, 2015).